Resource Central is a product of the Pediatric Pandemic Network.

Yale New Haven Health

This page includes a searchable index of all resources created by Yale New Haven Health and Yale University. If you would like to add a resource to this index, please contact us.

Loading...
4150 of over 80 results
EM Sim Cases: Pediatric Polytrauma
2020 · McGill University
The website describes a medical simulation case to help doctors practice managing complex injuries and communicating with families during stressful situations.. The focus is on …
Improving Palivizumab Administration to High-Risk Infants with Heart Disease via a Communication-Based Quality Improvement Initiative
2025 · Yale University, · Yale New Haven Health System
This article describes a project to improve the administration of palivizumab, a medication for high-risk infants with heart disease. A team at Yale University worked …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Prevention Firearm Injuries with Gun Safety Devices and Safe Storage: An Eastern Association for the Surgery of Trauma Systematic Review
2018 · Yale New Haven Health System, · Rutgers University, · Ventura County Medical Center, · University of Central Florida, · Atrium Health Carolinas Medical Center, · Eastern Association for the Surgery of Trauma
This article explores the impact of firearm storage methods on intentional and unintentional injuries. With over 50,000 firearm-related deaths annually, the study focuses on the …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Preventative Therapies for Respiratory Syncytial Virus (RSV) in Children: Where Are We Now?
2024 · Montreal Children's Hospital, · McGill University
This article reviews the current landscape of preventative therapies for respiratory syncytial virus (RSV) in children, focusing on the prefusion F protein as a key …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Challenges in Maximizing Impacts of Preventive Strategies Against Respiratory Syncytial Virus (RSV) Disease in Young Children
2022 · Yale University
This article discusses the challenges and advancements in preventive strategies against Respiratory Syncytial Virus (RSV) disease in young children. RSV is a common cause of …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in Infants: A Canadian Immunisation Research Network (CIRN) Study
2023 · York University, · Yale University, · Dalhousie University
This study looks at the cost-effectiveness of two strategies to prevent RSV disease in infants in Canada. It describes using nirsevimab, a long-acting antibody, for …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023 · Yale University, · York University, · Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
The Rapidly Changing Landscape of Respiratory Syncytial Virus Prophylaxis
2023 · University of Alberta, · McGill University
The article describes the changing ways to prevent respiratory syncytial virus (RSV) in Canada. New methods include a monoclonal antibody called nirsevimab and vaccines for …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Game Over for RSV?
2023 · Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024 · Yale School of Medicine, · Stanford University, · Seattle Children's Hospital, · The University of Chicago Medicine, · Nationwide Children's Hospital, · Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
4150 of over 80 results